Not everyone is happy about the MBS listing for left atrial appendage occlusion (LAAO) for stroke prevention in non‑valvular atrial fibrillation being restricted to patients contraindicated to lifelong oral anticoagulation therapy. Dr Karen Phillips, a cardiac electrophysiologist at HealthCare Partners in Brisbane, kicked off a debate at CSANZ 2018 with a spirited argument to open ...
LAAO benefits in doubt if Medicare listing is “reserved for the almost dead”
By Mardi Chapman
13 Aug 2018